News & Press
First Patient Dosed in Phase II Study
Moebius Medical Announces Dosing of First Patient in Global Phase IIb Clinical Trial of MM-II
learn more
FDA Clearance of IND
Moebius Medical Announces FDA Clearance of IND Application for Phase IIb Clinical Trial of MM-II, a Novel Treatment for Knee Osteoarthritis Pain
learn more
Abstract Accepted to OARSI 2020
Moebius Announces Acceptance of Abstract to OARSI 2020 Congress Showing MM-II’s Ability to Coat Cartilage in-vivo and Reduce Friction and Wear in ex-vivo Cartilage Models.
learn more
Archive
Sun Pharma & Moebius Medical
Sun Pharma & Moebius Medical Sign Exclusive Global Licensing Deal to Develop Novel Liposomal Non-opioid Pain Product for Osteoarthritis
learn more
Tech Tour Healthcare Summit
Moebius selected to present at Tech Tour Healthcare Summit
learn more
MIXiii BioMed 2017
Moebius shares its experience of negotiating with TTOs at MIXiii BioMed 2017 Conference

Startup Nation Conference, Miami
Moebius invited to participate in Startup Nation Conference – Miami

Moebius presents poster at OARSI
Moebius presents poster at OARSI highlighting results of first prospective randomized double-blinded study
learn more
American College of Rheumatology Meeting
Highlights of Moebius’s RCT presented at American College of Rheumatology Meeting
learn more
Poster presentation at AAOS
Poster presentation at AAOS demonstrating Safety and Efficacy of Liposome Intraarticular Injection in Moderate Knee Osteoarthritis
